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Donor site competition is involved in the
regulation of alternative splicing of
the rat b-tropomyosin pre-mRNA
CHARLIE DEGUI CHEN1,2 and DAVID M. HELFMAN1
1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
2Molecular and Cellular Biology Program, State University of New York at Stony Brook,
Stony Brook, New York 11790, USA
ABSTRACT
The rat b-tropomyosin (b-TM) gene encodes both skeletal muscle b-TM mRNA and nonmuscle TM-1 mRNA via
alternative RNA splicing. This gene contains eleven exons: exons 1–5, 8, and 9 are common to both mRNAs; exons 6
and 11 are used in fibroblasts as well as in smooth muscle, whereas exons 7 and 10 are used in skeletal muscle.
Previously we demonstrated that utilization of the 39 splice site of exon 7 is blocked in nonmuscle cells. In this study,
we use both in vitro and in vivo methods to investigate the regulation of the 59 splice site of exon 7 in nonmuscle cells.
The 59 splice site of exon 7 is used efficiently in the absence of flanking sequences, but its utilization is suppressed
almost completely when the upstream exon 6 and intron 6 are present. The suppression of the 59 splice site of exon 7
does not result from the sequences at the 39 end of intron 6 that block the use of the 39 splice site of exon 7. However,
mutating two conserved nucleotides GU at the 59 splice site of exon 6 results in the efficient use of the 59 splice site
of exon 7. In addition, a mutation that changes the 59 splice site of exon 7 to the consensus U1 snRNA binding site
strongly stimulates the splicing of exon 7 to the downstream common exon 8. Collectively, these studies demonstrate
that 59 splice site competition is responsible, in part, for the suppression of exon 7 usage in nonmuscle cells.
Keywords: cis-competition; RNA processing; splice site selection
INTRODUCTION
Alternative RNA splicing is a common mechanism reg-
ulating gene expression in eukaryotic cells (for re-
views, see Adams et al+, 1996; Wang et al+, 1997)+ By
this mechanism, a single gene can produce different
mRNAs that are translated into distinct protein iso-
forms often with different functions+ This process re-
quires precise splice site recognition and pairing in a
tissue- and developmental stage-specific manner (Reed,
1996; Wang et al+, 1997), and the mechanisms respon-
sible for splice site selection are just beginning to be
elucidated+
RNA splicing reactions take place in an RNA–protein
complex called the spliceosome+ The first step during
formation of the spliceosome is the assembly of the
commitment complex (for review, see Reed & Paland-
jian, 1997)+ The formation of the commitment complex
involves (1) direct base pairing between the sequences
in 59 splice sites and the 59 end of U1 snRNA, the RNA
component of U1 small nuclear ribonucleoprotein (U1
snRNP), which results in recognition of 59 splice site by
U1 snRNP, and (2) the association of polypyrimidine
tracts (PPT) immediately downstream of branchpoint
sequences (BPS) with U2 snRNP accessory factor
(U2AF)+ Because a commitment complex defines the
boundary of the intron that will be spliced, its formation
represents a primary step for the regulation of alterna-
tive splice site selection (Chabot, 1996)+ One determi-
nant for 59 splice site recognition is the degree of the
complementarity of the 59 splice site to the 59 end of U1
snRNA, with the consensus sequence AG:GUAA/GUA
being the most effective one (Eperon et al+, 1986;
Zhuang et al+, 1987; Lear et al+, 1990)+ Interestingly,
alternatively spliced exons often have suboptimal 59
splice sites (reviewed by Horowitz & Krainer, 1994)+
The association of U1 snRNP and 59 splice sites can
be regulated by other cis-acting elements and cellular
factors+A variety of cis-acting sequences in introns and
exons have been demonstrated to affect the recogni-
tion of 59 splice sites either through activation (Black,
1992; Dominski & Kole, 1992; Huh & Hynes, 1993;
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Humphrey et al+, 1995; Sirand-Pugnet et al+, 1995; El-
rick et al+, 1998) or by inhibition (Siebel et al+, 1992;
Elrick et al+, 1998)+ Both constitutive splicing factors
such as SR proteins and heterogeneous nuclear ribo-
nucleoprotein (hnRNP) proteins, and regulated splicing
factors such as KH-type splicing regulatory protein
(KSRP) and P element somatic inhibitor (PSI), have
been shown to affect the recognition of alternative 59
splice sites (Harper & Manley, 1991; Cáceres et al+,
1994; Kohtz et al+, 1994; Staknis & Reed, 1994; Yang
et al+, 1994; Zuo & Manley, 1994; Jamison et al+, 1995;
Min et al+, 1995, 1997; Screaton et al+, 1995; Siebel
et al+,1995;Tarn & Steitz,1995; Jumaa & Nielsen,1997)+
These proteins exert their effects on splice site selec-
tion presumably by binding to their cognate cis-acting
elements, stabilizing or unstabilizing the association of
U1 snRNP with 59 splice sites through direct protein–
protein interactions+ RNA secondary structures have
also been demonstrated to participate in the regulation
of splice site selection (D’Orval et al+, 1991; Libri et al+,
1991)+ The association of U2AF with the PPT in 39
splice site was found to be dependent upon the length
and pyrimidine content of the PPT (Mullen et al+, 1991;
Noble et al+, 1988), as well as on a number of other
cis-acting elements and trans-acting factors (Valcarcel
et al+, 1993; Wu & Maniatis, 1993; Lin & Patton, 1995;
Lynch & Maniatis 1996; Zhang & Wu, 1996; Zuo &
Maniatis, 1996; Buvoli et al+, 1997;Gooding et al+, 1998)+
We have been using the rat b-TM gene as a model
system to study the regulation of alternative RNA splic-
ing (Helfman et al+, 1986, 1988, 1990; Helfman & Ricci,
1989; Guo et al+, 1991; Mulligan et al+, 1992; Guo &
Helfman, 1993; Tsukahara et al+, 1994, Grossman
et al+, 1998)+ This gene consists of eleven exons; two
exon pairs, exons 6 and 7 and exons 10 and 11, are
alternatively spliced+ Exons 6 and 11 are used in TM-1
mRNA in nonmuscle cells, and exons 7 and 10 are
used in b-TM mRNA in skeletal muscle cells (Fig+ 1)+
Previous studies from our laboratory indicated that uti-
lization of the 39 splice site of exon 6 in nonmuscle cells
requires exon 8 sequences that contain three putative
exonic splicing enhancers (Helfman et al+, 1988; Tsu-
kahara et al+, 1994; Selvakumar & Helfman, 1999)+ This
led us to propose a model in which the splicing of
exon 6 in nonmuscle cells followed an ordered path-
way in which exon 6 must first join the downstream
common exon 8 before it can be spliced to the up-
stream common exon 5 (Helfman et al+, 1988; Guo &
Helfman, 1993)+ This model raises at least two ques-
tions+ First, how is the 39 splice site of exon 7 sup-
pressed in nonmuscle cells? This suppression is
established through cis-acting elements located in in-
tron sequence upstream of exon 7, designated as the
intron regulatory element (IRE), and probably also in
exon sequence at the 59 end of exon 7 (Helfman et al+,
1990; Guo et al+, 1991; Guo & Helfman, 1993)+ Further
studies indicated that a constitutive splicing factor, poly-
pyrimidine tract binding protein, as well as other pro-
teins such as FUSE binding protein and a homolog of
human Sam 68 tyrosine phosphoprotein, form a com-
plex on IRE and are possibly involved in blocking the
recognition of the 39 splice site of exon 7 in nonmuscle
cells (Mulligan et al+, 1992; Grossman et al+, 1998)+
Second, how is the 59 splice site of exon 7 suppressed
in nonmuscle cells? Suppression of the 59 splice site of
exon 7 is critical because it spares the 39 splice site of
exon 8 for exon 6, thus not only enabling exon 8 to be
spliced to exon 6 so that the 39 splice site of exon 6 can
be activated, but also excluding exon 7 from mRNA in
nonmuscle cells+ However, the mechanism underlying
this regulation remains to be determined+
In the present studies, we carried out a series of in
vitro and in vivo experiments to examine the roles of
intron, exon, and splice site sequences on the suppres-
sion of the 59 splice site of exon 7 in nonmuscle cells+
Our data demonstrate that utilization of the 59 splice
site of skeletal muscle-specific exon 7 in nonmuscle
cells is suppressed by competition of the alternative 59
splice site of nonmuscle-specific exon 6+ Thus, our data
extend our previously proposed model that utilization
of exon 6 in nonmuscle cells follows an ordered path-
way, and demonstrate that in addition to the blockage
of the 39 splice site, 59 splice site competition plays a
role in the exclusion of the skeletal muscle-specific
exon 7 in nonmuscle cells+
RESULTS
Sequences upstream of exon 7 are responsible
for suppressing the recognition of
the 59 splice site of exon 7
Our previous in vitro and in vivo data shows that a
minigene containing sequences from exon 5 to exon 8
contains enough cis-information to maintain the correct
exon choice in nonmuscle cells, in which exon 6 is
included and exon 7 is excluded (Helfman et al+, 1988)+
This data suggests that suppression of the 59 splice
site of exon 7 in nonmuscle cells is either an intrinsic
property, by which exon 7 cannot be spliced to exon 8,
even in the absence of its flanking sequences, or an
extrinsic effect, by which other sequences are required+
Exon 7 can be spliced efficiently to exon 8 in vitro using
a simple pre-mRNA that contains exon 7, intron 7, and
exon 8 in a HeLa cell system, which suggests that the
inability of exon 7 to join exon 8 in nonmuscle cells is
not an intrinsic property (Helfman & Ricci, 1989; Tsu-
kahara et al+, 1994)+ However, when the upstream
exon 6 and intron 6 were present, splicing of exon 7 to
exon 8 was undetectable (Helfman & Ricci, 1989)+ This
result suggests that sequences in intron 6, in exon 6, or
in both are responsible for suppression of the 59 splice
site of exon 7+ To extend these studies, we examined
the splicing of two substrates, 7(8/9) and 6(8/9), in
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HeLa cell nuclear extracts+ Substrate 7(8/9) consists of
exon 7, intron 7, and the joined exons 8 and 9; sub-
strate 6(8/9) includes the 39 half of exon 6 and the
entire intron 6 in the upstream of 7(8/9)+ As shown in
Figure 2, substrate 7(8/9) was spliced efficiently to form
the product exons 7 1 8/9 (Fig+ 2, lane 3), but splicing
of exon 7 to exon 8 was suppressed almost completely
when the upstream intron 6 and exon 6 were present
(Fig+ 2, lane 1); splicing of substrate 6(8/9) gave rise
only to product exons 6 1 8/9 (Fig+ 2, lane 1)+ The
intermediate and final products were identified accord-
ing to published data (Helfman & Ricci, 1989; Tsuka-
hara et al+, 1994), and further confirmed by the spliced
intermediate and final products of a deletion substrate
6(8/9)d25 that has a deletion of 76 nt in the IRE
(Fig+ 1)+ The splicing of 6(8/9)d25 gave rise to the same
product exons 6 1 8/9 as the wild-type substrate, but
the intermediate and final lariats from the splicing of
6(8/9)d25 were 76 nt shorter than those from the wild-
type substrate (Fig+ 2, lane 2)+ Interestingly, splicing of
6(8/9)d25 also gave rise to another spliced product
exon 6 1 exon 7 1 intron 7 1 exons 8/9, and the lariat
FIGURE 1. A: A schematic diagram of the rat b-tropomyosin pre-mRNA+ Open boxes represent constitutive exons; shaded
boxes represent tissue-specific exons as indicated+ Horizontal lines represent introns (not drawn to scale)+ B: Nucleotide
sequence from exon 6 to exon 8 of the rat b-tropomyosin pre-mRNA+ The upper cases are exon sequences and the lower
cases are intron sequences+ d25 deletes the sequence within the two sites marked d25+ cd, cd27, and cd22 contain
sequences from the 39 end of intron 6 to their respectively marked locations (Helfman et al+, 1990)+ In ex-1, UGUGGG is
mutated to GGAUCC (Guo et al+, 1991)+ Primers Int6 and Ex8 used in the PCR reactions are underlined, and the restriction
enzyme sites for NcoI and Pst I that were used to confirm the identities of in vivo products are also indicated+
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derived from the deleted intron 6+ This suggests that
sequences in the IRE do not play a role in preventing
the use of the 59 splice site of exon 7+ These results
confirm that suppression of the 59 splice site of exon 7
requires the sequences in intron 6, exon 6, or both+
The proposed secondary structure is not
responsible for suppression of
the 59 splice site of exon 7
Studies of the chicken b-TM pre-mRNA have revealed
that a secondary structure formed by the sequences in
and around the skeletal muscle-specific exon is respon-
sible for the suppression of its 59 splice site usage in
nonmuscle cells (D’Orval et al+, 1991; Libri et al+, 1991)+
A similar secondary structure was also proposed to be
present in the rat b-TM gene (Helfman et al+, 1990)+ In
addition, two types of mutations, one deleting or mu-
tating the IRE sequence and the other mutating the
exon sequence UGUGGG at the 59 end of exon 7 to
GGAUCC(ex-1) (Fig+ 1B), have been shown to activate
the utilization of skeletal muscle-specific exon 7 in HeLa
cells in vitro and in vivo (Helfman et al+, 1990; Guo
et al+, 1991); these two types of mutations alter se-
quences that are important for the formation of the
putative secondary structure+ From these results, we
speculated that the putative secondary structure in the
rat b-TM gene may also be responsible for the sup-
pression of the 59 splice site of exon 7+ In order to test
this hypothesis, we examined the effects of the d25
and ex-1 mutations on the utilization of the 59 splice
site of exon 7 in the context of 6(8/9)+ Instead of using
BamHI to linearize the templates for synthesizing the
substrates as in Figure 2, we used EcoRI because the
sequence of the ex-1 mutation produces a BamHI site+
Substrates synthesized using templates linearized by
EcoRI are 18 nt longer than those linearized with BamHI+
To determine the kinetics of splicing, a time course
splicing reaction was carried out+ Splicing of the wild-
type substrate generated only one product: exons 6 1
8/9 (Fig+ 3, lanes 1–3)+ Splicing of the deletion mutant
d25 also gave rise to product exons 6 1 8/9, with the
same kinetics as the wild-type substrate had (Fig+ 3,
lanes 7–9)+ However, this deletion did not activate the
59 splice site of exon 7, as we did not detect any of the
cleaved exon 6 1 intron 6 1 exon 7, the intermediate
lariat intron 7 1 exons 8/9, the final lariat intron 7, or the
final product exon 6 1 intron 6 1 exon 7 1 exons 8/9,
as these intermediates or products would be generated
if the 59 splice site of exon 7 was activated+ Instead, the
final lariat derived from the deleted intron 6 was de-
tected (Fig+ 3, lanes 7–9), which indicates that the de-
letion of the IRE sequence does not activate the 59
splice site of exon 7 but, instead, the 39 splice site of
exon 7+ Besides the product exons 6 1 8/9, splicing of
the ex-1 mutation also gave rise to the lariat derived
from intron 6 (Fig+ 3, lanes 4–6)+ Splicing of the ex-1
mutation produced less spliced product exons 6 1 8/9
than the wild-type substrate because exon 6 was also
spliced to exon 7 to form exon 6 1 exon 7 1 intron 7 1
exons 8/9+ This result suggests that the ex-1 mutation
has the same effect as d25, that is, activation of the 39
splice site of exon 7+ We could not detect the product
exon 6 1 exon 7 1 intron 7 1 exons 8/9 when d25 was
spliced (compared to Fig+ 2, lane 2) because products
derived from the substrates linearized by EcoRI were
not stable in this batch of HeLa cell nuclear extract, as
can be seen from the fuzzy final product exons 6 1 8/9+
These data demonstrate that the putative secondary
structure is not responsible for the suppression of the
59 splice site of exon 7+
FIGURE 2. Cis-acting elements required for the suppression of the
59 splice site of exon 7 are located in sequences upstream of exon 7+
A: Schematic diagrams of the splicing substrates+ B: The pre-
mRNAs were transcribed in a standard run-off transcription reaction,
subjected to in vitro splicing reactions for 2 h, and the products were
separated in a 4% denaturing polyacrylamide gel+ Schematic repre-
sentations of the precursors and products are indicated+ The cleaved
exon 6 ran out of the gel because of its small size+ IVS: intervening
sequences+
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The upstream intron sequences do not affect
the efficient utilization of the 59 splice site
of exon 7
To determine whether the sequence in intron 6 is re-
sponsible for the suppression of the 59 splice site of
exon 7, we generated three substrates that contain
different lengths of intron 6 starting from the 39 end+
These substrates contain 274 nt (cd), 170 nt (cd27), or
94 nt (cd22) of intron 6 sequences upstream of 7(8/9)
(Fig+ 1B, Fig+ 4A)+ The substrates were subjected to the
in vitro splicing assay+ As shown in Figure 4B, the 59
splice sites of exon 7 were used to splice to exon 8
efficiently with all substrates+ Because different sub-
strates contain different lengths of the intron 6 se-
quences upstream of exon 7, the spliced product from
each substrate migrated to a different position+ How-
ever, the intermediates and final lariats are the same
and their intensities were comparable for different sub-
strates+ Although in this experiment the intensities of
both intermediate and final lariats from the splicing of
cd22 were weaker than those of others, cd22 was
spliced with the same efficiency in other experiments+
These results demonstrate that the sequences in intron
6 are not responsible for suppressing the 59 splice site
of exon 7+ We also found that this suppression was not
due to the sequences in exon 6 because substituting
exon 6 sequence with exon 1 of the human b-globin
gene or exon 5 of the rat b-TM gene in the context of
6(8/9) also suppressed the splicing of exon 7 to exon 8
(data not shown)+
Donor site competition is responsible for
the suppression of the 59 splice site
of exon 7 in vitro
The above-mentioned results demonstrated that spe-
cific sequences in either intron 6 or exon 6 were not
required for the suppression of the 59 splice site of
A
FIGURE 3. Disruption of the putative secondary structure does not
relieve the suppression of the 59 splice site of exon 7+ A: The pro-
posed secondary structure+ B:Autoradiograph of a time-course splic-
ing+ Transcriptions were carried out as described in Figure 2 except
that EcoRI was used to linearize the templates instead of BamHI,
and in vitro splicing reactions were incubated for the time indicated at
the top of the panel+ Schematic representations of the precursors
and final products are indicated+
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exon 7+ However, we had not studied the role of the first
17 nt in intron 6+ Because this sequence contains the
59 splice site of exon 6, it is possible that the 59 splice
site of exon 6 is responsible for the regulation of the 59
splice site of exon 7+ Thus, we hypothesized that the
59 splice site of exon 6 competes with that of exon 7 to
splice to exon 8, thereby suppressing the 59 splice site
of exon 7+ To test this hypothesis, we examined the
splicing of three substrates in which two conserved
nucleotides GU at the 59 splice site of exon 6 were
mutated to either GG, GA, or AU+ When these mutated
substrates were tested for splicing, the formation of the
product exons 6 1 8/9, which the wild type produced
(Fig+ 5, lane 1),was abolished+ Instead, splicing of these
mutant substrates gave rise to a product containing
exon 6 1 intron 6 1 exon 7 1 exons 8/9 (Fig+ 5, lanes 3–
FIGURE 4. Sequences in intron 6 are not involved in the suppres-
sion of the 59 splice site of exon 7+ A: A schematic diagram of the
substrates+ Intron 6 sequences retained in the substrates are indi-
cated as numbers above the intron upstream of exon 7+ B: Auto-
radiograph of the in vitro splicing+ The precursors, intermediates, and
final products are indicated+
FIGURE 5. Cis-competition is responsible for the suppression of the
59 splice site of exon 7 in vitro+ Transcription and in vitro splicing
reactions were carried out as described in Figure 2 with the excep-
tion that the RNA molecules were separated in denaturing 6% PAGE
gel+A schematic diagram of the different mutated substrates is shown
at the top; the precursors, intermediates, and final products are in-
dicated on the left+ A lighter exposure is also shown on the right+ In
ex7c, GUAUAG is mutated to GUAAGU+ ex6gg, ex6ga, and ex6at
are mutations of the 59 splice site of exon 6+
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5)+ These results suggest that the 59 splice site of
exon 6 is preferred to that of exon 7 in HeLa cell nu-
clear extract in vitro+
Another way to examine cis-competition between two
59 splice sites is to strengthen the weak one to deter-
mine if this change leads to an increasing utilization of
the improved splice site+ Therefore, we examined splic-
ing of a substrate ex7c in which sequence of the 59
splice site of exon 7 (AG:GUAUAG) was mutated to the
consensus sequence (AG:GUAAGU) of the U1 snRNP
binding site+ Strengthening the 59 splice site of exon 7
resulted in its efficient usage, as evidenced by the for-
mation of spliced product exons 7 1 8/9 (Fig+ 5, lane 2)+
It is not surprising that the level of the spliced product
exons 6 1 8/9 that uses the 59 splice site of exon 6 was
maintained, because the splicing efficiency of exon 6 to
exon 8 is high, and the standard splicing reaction uses
an excess amount of HeLa cell nuclear extract+ These
data confirm our conclusion that utilization of the 59
splice site of exon 7 is suppressed by competition from
the 59 splice site of the alternative exon 6 in nonmuscle
cells+
In vivo study of donor site competition
We previously reported that the mutations or deletions
of the 59 splice site of exon 6 did not result in increasing
use of exon 7 in nonmuscle cells in vivo (Guo et al+,
1991), which is inconsistent with the in vitro results
described above+ However, in the previous experi-
ments, cytoplasmic mRNA was used in an RNA pro-
tection assay, by which only the fully spliced products
would have been detected+ Thus, it is possible that the
effects of the deletions or mutations of the 59 splice site
of exon 6 on the utilization of the 59 splice site of exon 7
might not have been observed because the 39 splice
site of exon 7 is still blocked+ To examine this possibility
and to determine whether donor site competition occurs
in vivo, we performed transient transfection assays in
HeLa cells using the same series of p2 substrates as in
the previous experiments+ p2 consists of the rat b-TM
gene fragment from exon 5 to exon 9, and it has been
demonstrated to contain enough information for the reg-
ulation of mutually exclusive splicing of exons 6 and 7
in HeLa cells (Helfman et al+, 1988)+ Instead of isolating
cytoplasmic mRNA and using an RNA protection assay,
whole-cell RNA was isolated 48 h after the transfection
and analyzed using reverse transcription-polymerase
chain reaction (RT-PCR)+ This assay facilitates the de-
tection of intermediate products+When we used a sense
primer (SV40) homologous to the SV40 promoter and
an antisense primer (Ex8) complementary to exon 8,
we detected a major PCR product corresponding to
spliced products exons 5 1 6 1 8 or exons 5 1 7 1 8
(both are at the same size), and a skipping product
containing exons 5 1 8 from cells transfected with the
wild-type substrate (Fig+ 6A, lane 2)+
To determine if the major PCR product contained
exon 6 or exon 7, the products were digested with NcoI
because exon 6 contains a NcoI site+ The major prod-
uct was composed of exons 5 1 6 1 8, as it was com-
pletely digested by NcoI (Figs+ 1B and 6A, lane 3)+
These results are consistent with our previous data
(Guo et al+, 1991; Guo & Helfman, 1993)+ In contrast,
when the 59 splice site of exon 6 was mutated from GU
to GG or AU, a significantly increasing amount of the
skipping product containing exons 5 1 8 was detected
(Fig+ 6A, lanes 4–7)+ Furthermore, the mutation con-
verting the 59 splice site of exon 7 to the consensus
sequence of U1 snRNP binding site reduced the level
of the product exons 5 1 6 1 8 about half-fold (Fig+ 6A,
lane 8; Fig+ 6B)+ This mutation also gave rise to a de-
tectable amount of the product containing exons 5 1
7 1 8, as NcoI could not completely digest the band
corresponding to the product exons 5 1 6 1 8 or ex-
ons 5 1 7 1 8 (Fig+ 6A, lane 9; Fig+ 6B)+ It is worth
noting that a significant amount of the product ex-
ons 5 1 6 1 7 1 8 was also detected from cells trans-
fected with the ex7c mutant (Fig+ 6A, lane 8; Fig+ 6B)+
This result supports our hypothesis that the regulation
of the 59 splice site of exon 7 is important for the mu-
tually exclusive splicing of exons 6 and 7; deregulation
of the 59 splice site of exon 7 leads to the inclusion of
skeletal muscle-specific exon 7 in nonmuscle cells+ The
product exons 5 1 7 1 8 was not detected when the 59
splice site of exon 6 was mutated (Fig+ 6A, lanes 4–7),
which is consistent with our model that suppression of
the 39 splice site of exon 7 is important to block the
utilization of exon 7 in nonmuscle cells (Guo & Helf-
man, 1993)+ Because digestion of the product ex-
ons 5 1 6 1 7 1 8 by NcoI also gave rise to exon 5 1
half of exon 6, the intensities of this digested product
exon 5 1 half of exon 6 were comparable between the
wild-type and mutant ex7c+ We could not detect the
intermediate product exon 5 1 intron 5 1 exon 6 1
intron 6 1 exons 7 1 exon 8 using this pair of primers,
which is probably because of the competition with the
short PCR products for amplification+
To determine whether any intermediate products were
present in the transfected cells, we carried out PCR
reactions using another sense primer, Int6, homolo-
gous to the intron 6 sequence, together with the anti-
sense primer Ex8+ This pair of primers allowed us to
detect the intermediate in which exon 7 is spliced to
exon 8 and the product also contains intron 6+ The
expected PCR product is 175 nt long and can be
digested by restriction enzyme Pst I to generate a prod-
uct containing exons 7 1 8 (123 nt) because a Pst I
site is at the boundary between intron 6 and exon 7
(Fig+ 1B)+ A low level of splicing intermediate intron 6 1
exons 7 1 8 was detected from cells transfected with
the wild-type substrate (Fig+ 6C, lanes 3 and 4), which
is consistent with our previous result (Guo et al+, 1991)+
When the 59 splice site of exon 6 was mutated from GU
296 C.D. Chen and D.M. Helfman
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to GG or AU, splicing of exon 7 to exon 8 was signifi-
cantly increased (Fig+ 6C, lanes 5–8)+ The ex7c muta-
tion also increased the splicing of exon 7 to exon 8
(Fig+ 6C, lanes 10 and 11)+ The digested product ex-
ons 7 1 8 was a doublet because the two strands differ
by 4 nt and were separated in denatured gel+ An equal
amount of exogenous RNA from different transfected
cells was used in the RT-PCR reactions (Fig+ 6D)+ Col-
lectively, these results indicate that donor site compe-
tition is responsible for suppressing the 59 splice site of
exon 7 in nonmuscle cells in vivo+
DISCUSSION
In the present paper we demonstrate that the 59 splice
site of the skeletal muscle-specific exon 7 is regulated
in nonmuscle cells+ Our studies show that donor site
competition is responsible for the suppression of the 59
B
FIGURE 6. In vivo analyses of cis-competition+ A: RT-PCR amplifi-
cations of the spliced products using primers SV40 and Ex8, and the
total RNA as templates+ The undigested products were separated in
lanes 2, 4, 6, and 8, and the NcoI digested products were in lanes 3,
5, 7, and 9, as visualized by ethidium bromide staining+ The plasmids
used in the transfections are indicated at the top, and the undigested
and digested products on the right+ B: Quantitation of the in vivo
spliced products+ Splicing efficiency is the percentage of a product
divided by total exogenous RNA from the same cells and derived
from three independent experiments+ C: RT-PCR amplification of the
spliced intermediates using primers Int6 and Ex8, and the total RNA
as templates+ Lane 1 shows the RT-PCR without templates+ The
undigested products are separated in lanes 3, 5, 7, and 9, and the
Pst I digested products are in lanes 4, 6, 8, and 10, as visualized by
ethidium bromide staining+ The substrates used in this assay are
indicated at the top; the digested and undigested products are indi-
cated on the right and the marker on the left+ D: RT-PCR demon-
strates that equal amounts of the exogenous RNAs were used in A
and C using primers SV40 and Ex5+
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splice site of exon 7, and furthers our understanding of
the regulation of alternative splicing of the rat b-TM gene+
Until now, it was not known how the 59 splice site of
exon 7 is regulated+ One simple mechanism we con-
sidered is that a trans-acting factor(s) selectively re-
presses the 59 splice site of exon 7 in nonmuscle cells+
This mechanism has been demonstrated to affect 59
splice site selection in other pre-mRNAs+ The PSI, a
somatic cell-specific splicing factor in Drosophila, binds
to an exon inhibitory sequence and blocks the binding
of U1 snRNP to the authentic 59 splice site+ This leads
to inhibition of splicing of the P element third intron in
somatic cells (Siebel et al+, 1995)+ SF2/ASF has been
suggested to inhibit the recognition of splice donor site
in alternatively spliced SRp20 gene (Jumaa & Nielsen,
1997)+ However, this type of trans-regulation seems
unlikely to be responsible for the suppression of the 59
splice site of exon 7 in the b-TM pre-mRNA because
sequences of intron 6 and exon 6 outside of the 59
splice site of exon 6 play no role on this regulation
(Fig+ 4)+ Another possibility we considered is that se-
quences in and flanking exon 7 are involved in the
formation of an inhibitory secondary structure, which
prevents the recognition of the 59 splice site of exon 7+
The involvement of the upstream intron sequence in
the regulation of the downstream exon splicing has
been demonstrated in the chicken b-TM pre-mRNA
(D’Orval et al+, 1991; Libri et al+, 1991)+ In the chicken
pre-mRNA, sequences in and around the skeletal
muscle-specific exon form a secondary structure,which
masks the recognition of the 59 splicing site of the skel-
etal muscle-specific exon in nonmuscle cells+ We pre-
viously proposed a similar secondary structure that may
be involved in the regulation of the rat b-TM gene (Helf-
man et al+, 1990)+ However, we found no evidence for
such regulation because deletions or mutations of the
sequences involved in the formation of this putative
secondary structure did not activate its downstream 59
splice site (Fig+ 3)+
Our data demonstrate that splice site competition is
responsible for the suppression of the 59 splice site of
exon 7: exon 7 was used when two conserved nucle-
otides GU at the 59 splice site of exon 6 were mutated
or when the 59 splice site of exon 7 was improved
(Figs+ 5 and 6)+ The sequences of 59 splice sites have
been demonstrated to be critical for their recognition in
both constitutive and alternative splicing (Eperon et al+,
1986; Aebi et al+, 1987; Zhuang et al+, 1987; Lear et al+,
1990)+ Although the sequences of 59 splice sites are
more or less deviated from the consensus (reviewed in
Horowitz & Krainer, 1994), it is a general phenomenon
that the consensus sequence is preferably recognized
by the splicing machinery (Eperon et al+, 1986), and
there is a sequence hierarchy for 59 splice site prefer-
ence (Gallego & Nadal-Ginard, 1990; Lear et al+, 1990)+
Our data indicate that the AG:GUAGUA sequence of
the 59 splice site of exon 6 (a purine insertion between
AG in positions 3 and 4 would make it a perfect match
to the consensus), matches better the consensus
AG:GURAGU than the AG:GUAUAG sequence of the
59 splice site of exon 7 does+As a consequence, the as-
sociation of U1 snRNP with the 59 splice site of exon 6
is stronger than with that of exon 7+ It is possible that a
factor(s) associated with U1 snRNP is limited so that the
commitment complex can only be formed between the
donor site of exon 6 and the acceptor site of exon 8,
which results in the exclusion of exon 7 in nonmuscle
cells+ In contrast, in skeletal muscle cells, the 59 splice
site of exon 7 may be activated by an activator such as
SF2/ASF+ This protein was shown to activate the donor
site of exon 7 in nonmuscle cells in vitro (Meyeda et al+,
1993), but not in vivo (Cáceres et al+, 1994)+
Splice site competition has been found to be respon-
sible for splice site selection in several alternatively
spliced exons+ In the chicken b-TM gene, the donor
site of exon 6b (GA:GUAUGA) is preferred to that of
exon 6a (GA:GUACTG); this preference results in uti-
lization of exon 6b in myotubes (Libri et al+, 1992)+ In
the rat fibronectin gene, exon EIIIB is not used be-
cause its 59 splice site is outcompeted by a stronger
one in exon III-8b (Huh & Hynes, 1993)+ Furthermore,
the production of E1A 13S mRNA at early times after
adenovirus infection results from a bona fide cis-
competition between two 59 splice sites for 13S and
12S (Harper & Manley, 1991)+ Similarly, 39 splice site
competition has also been demonstrated to be in-
volved in splice site selection+ Because binding of U2AF
to the PPT immediately downstream of the BPS is a
prerequisite for the association of U2 snRNP with the
branchpoint (Wang et al+, 1995; Valcarcel et al+, 1996;
Rudner et al+, 1998), the contents of PPT significantly
affects the recognition of 39 splice sites+ A long PPT
located downstream of the branchpoint in the IVS 3 of
a-TM pre-mRNA makes the branchpoint of IVS 3 stron-
ger than that of IVS 2; this difference results in the
default utilization of exon 3 in most cell types except for
the smooth muscle cells (Mullen et al+, 1991)+ 39 splice
site competition was also found to be involved in the
regulation of the chicken b-TM pre-mRNA (Libri et al+,
1992)+ The strength difference of the BPSs was also
shown to control alternative splice-site selection in SV40
early pre-mRNA splicing (Noble et al+, 1988)+
The regulation of alternative splicing of the rat b-TM
gene is similar to that of the chicken gene in that both
intron sequences immediately upstream of skeletal
muscle-specific exon and exon sequences at the 59
end of that exon are involved in the suppression of its
39 splice sites in nonmuscle cells (Helfman et al+, 1990;
Guo et al+, 1991; Guo & Helfman, 1993; Gallego et al+,
1996)+ In addition, each of the genes contains an un-
usually long distant BPS for skeletal muscle-specific
exon 7 (exon 6b in the chicken gene) (Helfman & Ricci,
1989; Goux-Pelletan et al+, 1990)+ However, the results
presented here suggest that the regulation of the 59
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splice sites of the skeletal muscle-specific exon is dif-
ferent in mammalian and avian systems+ We show that
in the rat b-TM gene, the 59 splice site of exon 7 is
suppressed due to competition of the 59 splice site of
exon 6 in nonmuscle cells+ In contrast, a secondary
structure formed by the sequences in and around the
skeletal muscle-specific exon masks the recognition of
its 59 splice site in the chicken b-TM gene in nonmuscle
cells (D’Orval et al+, 1991; Libri et al+, 1991)+Our present
data argue that a similar secondary structure is not
involved in the 59 splice site suppression of the skeletal
muscle-specific exon in the rat b-TM gene because
disruptions of the putative secondary structure did not
activate its 59 splice site (Fig+ 3)+ Our results are con-
sistent with the conclusion that the splicing of the al-
ternative exons of the chicken and rat b-TM genes
requires different regulatory elements (Balvay et al+,
1994)+ Expression of the chicken minigene in mouse
cells results in inclusion of both mutually exclusive ex-
ons, and expression of the rat minigene in quail myo-
blasts causes the usage of exon 7+
Our present data extend our model that exon 6 has to
be joined to the downstream common exon 8 before it
can be spliced to the upstream common exon 5 in non-
muscle cells (Guo & Helfman, 1993), and further our un-
derstanding of how exon 7 is regulated+ Two cis-acting
elements, one in the intron upstream of exon 7 and the
other at the 59 end of exon 7, are involved in blocking
the utilization of the 39 splice site of exon 7 (Helfman
et al+, 1990;Guo et al+, 1991;Guo & Helfman, 1993)+We
show that the 59 splice site of exon 7 is suppressed by
competition of the 59 splice site of exon 6 in this study+
The inability to use both the 59 and 39 splice sites of
exon 7 allows exon 6 to be spliced to exon 8, fulfilling
the requirement that joining of exon 8 to exon 6 is nec-
essary for the usage of exon 6+ These data also sug-
gest that splicing of exon 6 to exon 8 is a default pathway
in nonmuscle cells, and that tissue-specific factors may
be present in skeletal muscle cells+ These factors either
suppress the 59 splice site of exon 6, activate the 59 splice
site of exon 7, or both+ Alternatively, skeletal muscle-
specific factors may activate the 39 splice site of the
skeletal muscle-specific exon 7, resulting in joining of
exon 7 to exon 5 and exclusion of exon 6+ We cannot
exclude other possible mechanisms that may be involved
in the activation of exon 7 in skeletal muscle cells+ We
have recently developed an in vitro system to identify
skeletal muscle-specific factors (Wang Y-C, Liu J-P,
Krainer AR, Helfman DM, in prep+) and experiments are
in progress to identify these proteins+
MATERIALS AND METHODS
Plasmid construction
The DNA templates for synthesizing in vitro splicing sub-
strates were all in an pSP64 vector that contains an SP6
promoter, and derived from the rat b-TM gene (Helfman et al+,
1988)+ p6(8/9) was constructed from pSP64-p2p6(8/9) (Tsu-
kahara et al+, 1994) by deleting sequences from Hind III site
in polylinker to NcoI site in exon 6, filled in by the Klenow
fragment, and re-ligated with a Hind III linker+ The resulting
construct contained 43 nt of the 39 part of exon 6+ p6(8/9)d25
was derived from p6(8/9) by switching the respective PCR
fragment from NcoI in exon 6 to Pst I at the 39 end of intron 6
using pSp64-p2(7/8)d25 (Helfman et al+, 1990) as a tem-
plate; the NcoI site was changed to Hind III site+ The ex-1
mutation, mutations that alter the 59 splice site of exon 6 from
GU to GG, GA, or AU (ex6gg, ex6ga, ex6au), and the muta-
tion that converts the sequence GUAUAG at the 59 splice site
of exon 7 to the consensus sequence GUAAGU were gen-
erated by site-directed mutagenesis (Kunkel, 1985)+ The con-
structs were verified by sequencing+
The plasmids used in in vivo transfection experiments have
been described previously (Helfman et al+, 1988)+
Synthesis of RNA and in vitro splicing
The 32P-labeled splicing substrates were synthesized in vitro
and primed with Cap analog, as described by Konarska et al+
(1984)+The 32P-labeled pre-mRNAs contained a small amount
of prematurely terminated transcripts, but their presence did
not affect the in vitro splicing reaction, and the RNA sub-
strates were not purified further+
HeLa cell nuclear extracts were prepared as described
earlier (Dignam et al+, 1983; Krainer et al+, 1984)+ In vitro
splicing reactions were carried out at 30 8C for 2 h unless
otherwise indicated+ Standard splicing conditions used for
these studies consisted of 15 mL of HeLa cell nuclear extract
in a final reaction volume of 25 mL, containing 2 mM MgCl2,
0+5 mM ATP, 20 mM creatine phosphate, 15 ng pre-mRNA,
12+8 mM HEPES (pH 8), 14% (v/v) glycerol, 60 mM KCl,
0+12 mM EDTA, and 0+3 mM dithiothreitol+
Transfection and RNA analysis
HeLa cells were grown in Dulbecco’s modified Eagle medium
supplemented with 5% fetal bovine serum, and transfected
with 5 mg of plasmid DNA per 100-mm plate by using a
calcium phosphate coprecipitation procedure; cells were har-
vested 48 h later, and whole-cell RNA was isolated as de-
scribed (Gilman, 1988)+ Reverse transcription was carried
out using 10 mg whole-cell RNA and 100 mmol random prim-
ers in 30 mL reaction+ To determine the spliced products, a
sense primer SV40: TTTTGGAGGCCTAGGCTTTT, homol-
ogous to the SV40 promoter, and an antisense primer Ex8:
TCCAGAAGTTTGATCTC-TTC, complementary to exon 8,
were used in PCR reactions+ In some experiments, the prim-
ers were 32P-labeled by T4 polynucleotide kinase+ Half of
each PCR product was directly mixed with Pst I for digestion,
and the undigested and digested PCR products were run in
a denaturing gel and visualized by either ethidium bromide
staining or autoradiograph+ To amplify the intermediates, a
sense primer Int6: CTGTCTCACCTCACTGTGC, homolo-
gous to the intron 6 sequence, and the antisense primer Ex8
were used in PCR reactions+ Half of each PCR product was
directly mixed with NcoI for digestion, and the undigested
and digested PCR products were run in a denaturing gel and
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visualized by ethidium bromide staining+ To determine the
amount of the exogenous RNA used in the RT-PCR reac-
tions, PCR reactions were carried out by using the sense
primer SV40 and an antisense primer Ex5: GCCTCCTCGG
CTCTCTCT, complementary to the exon 5 sequence+ PCR
products were run in an agarose gel and visualized by ethid-
ium bromide staining+All of the PCR reactions were run for 20
cycles (94 8C, 55 8C, and 72 8C) to maintain linear amplification+
To quantify the in vivo spliced products, ethidium bromide
staining or autoradiograph films were scanned on a UMAX
UC630 MaxColor scanner using Adobe PhotoshopTM 2+5 soft-
ware at 300 dpi and quantitation was made using NIH image
1+6 software with the built-in logarithmic calibration+
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